High-density lipoprotein: Multipotent effects on cells of the vasculature

International Review of Cytology

Volumn 188, Issue , 1999, Pages 257-297

  Cockerill, Gillian W ^a   Reed, Stephen ^b  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b UNIVERSITY OF WESTMINSTER   (United Kingdom)

Author keywords

Acute phase reactants; Apolipoproteins; Atheroclerosis; HDL; Inflammation; Thrombosis; Vasoactive agents

Indexed keywords

ACUTE PHASE PROTEIN; APOLIPOPROTEIN; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; VASOACTIVE AGENT;

ATHEROSCLEROSIS; BLOOD VESSEL; CARDIOVASCULAR DISEASE; CELL; CHOLESTEROL TRANSPORT; LIPOPROTEIN BLOOD LEVEL; PRIORITY JOURNAL; REVIEW;

ACUTE-PHASE PROTEINS; ANIMALS; APOLIPOPROTEINS; ARTERIOSCLEROSIS; CORONARY DISEASE; ENDOTHELIUM, VASCULAR; HUMANS; LIPOPROTEINS, HDL;

EID: 0032410217     PISSN: 00747696     EISSN: None     Source Type: Book Series    
DOI: 10.1016/s0074-7696(08)61569-7     Document Type: Article

References (179)

1. Abbassi, O., Kishimoto, T. K., Mclntire, L. V., Anderson, D. G, and Smith, G W. (1993). E-selectin supports neutrophil rolling in vitro under conditions of flow. J. Clin. Invest. 92, 2719-2730.
2. Acton, S., Rigotti, A., Landschultz, K. T., Hobbs, H ., and Krieger, M. (1996). Identification of scavenger receptor SR-B1 as a high density lipoprotein receptor. Science 271, 518-520.
3. Albers, J. J., Tollefson, J. H., Chen, G H ., and Steinmetz, A. (1984). Isolation and characterisation of human lipid transfer proteins. Arteriosclerosis 4, 49-58.
4. Aoyama, T., Yui, Y., Morishita, H ., and Kawai, C. (1990). Prostaglandin 12 half-life regulated by high density lipoprotein is decreased in acute myocardial infarction and unstable angina pectoris. Circulation 81, 1784-1791.
5. Aviram, M ., and Brooks, J. G. (1983). Characterisation of the effect of plasma lipoproteins on platelet function in vitro. Haemostasis 13, 344-350.
6. Badimon, J. J., Badimon, L ., and Fuster, V. (1990). Regression of atherosclerotic lesions by high density lipoprotein plasma fraction in the cholesterol fed rabbit. J. Clin. Invest. 85, 1234-1241.
7. Bath, P. M., Gladwin, A. M ., and Martin, J. F. (1991). Human monocyte characteristics are altered in hypercholesterolaemia. Atherosclerosis 90,175-181.
8. Beckman, J. S., Beckman, T. \V., Chen, J., Marshall, P. A ., and Freeman, B. A. (1990). Apparent hydroxyl radical production by peroxinitrite: Implication for endothelial injury from nitric oxide and Superoxide. Proc. Nail. Acad. Sei. USA 87, 1620-1624.
9. Beitz, A., Beitz, J ., and Mest, H.-J. (1994). Is the antiatherosclerotic potency of HDL modulated by the origin of HDL? Prostaglandins Leukocyte Essential Fatty Acids 50, 115-121.
10. Benditt, E. P ., and Eriksen, N. (1977). Amyloid protein SAA is associated with high density lipoprotein from human serum. Proc. Natl. Acad. Sei. USA 74, 4025-4028.
11. Bennett, M. R., Evan, G. I ., and Schwartz, S. M. (1995). Apoptosis of human vascular smooth muscle cells derived from normal vessels and coronary atherosclerotic plaques. J. Clin. Invest. 95, 2266-2274.
12. Bevilacqua, M. P., Pober, J. S., Mendrick, D. L., Cotran, R. S ., and Gimbrone, M. A., Jr. (1987). Identification of an inducible endothelial-leukocyte adhesion molecule. Proc. Natl. Acad. Sei. USA 84, 9238-9242.
13. Bevilacqua, M. P., Stengelin, S., Gimbrone, M. A., Jr ., and Seed, B. (1989). Endothelial leukocyte adhesion molecule-1: An inducible receptor for neutrophils related to complement regulatory proteins and lectins. Science 243, 1160-1165.
14. Bjorkerud, S ., and Bjorkerud, B. (1994). Lipoproteins are major and primary mitogens and growth promoters for human arterial smooth muscle cells and lung fibroblasts in vitro. Arterioscler. Thromb. 14, 288-298.
15. Blackburn, W. D., Jr., Dohlman, J. G., Venkatachalapathi, Y. V., Pillion, D. J., Koopman, W. J., Segrest, J. P ., and Anantharamaiah, G. M. (1991). Apolipoprotein A-I decreases neutrophil degranulation and Superoxide production. J. Lipid Res. 32,1911-1918.
16. Blann, A. D., Goode, G. K., Miller, J. P ., and McCollum, C. N. (1995). Soluble P-selectin in hyperlipidaemia with and without symptomatic vascular disease: Relationship with von Willebrand factor. Blood Coag. Fibrinol. 8, 200-204.
17. Bochkov, V., Tkachuk, V., Buhler, F ., and Resink, T. (1992). Phosphoinositide and Ca signalling responses in SMC: Comparison between lipoproteins, angiotensin II and PDGF. Biochem. Biophys. Res. Commun. 188, 1295-1304.
18. Boulanger, C. M., Tanner, F. C, Bea, M.-L., Hahn, A. W. A., Werner, A ., and Luscher, T. F. (1992). Oxidised low density lipoproteins induce mRNA expression and release of endothelin from human and porcine endothelium. Circ. Res. 70, 1191-1197.
19. Buckley, C. D., Dayannas, R., Newton, J. P., Blyston, D. S., Brown, E. S., Watt, S. M ., and Simmons, D. L. (1996). Identification of alpha v beta 3 as a heterotypic ligand for CD31/ PECAM-1. J. Cell Sei. 109, 437-445.
20. Cabana, V. C., Lukens, J. R., Rice, K. S., Hawkins, T. J ., and Getz, G. S. (1996). HDL content and composition in acute phase response in three species: Triglyceride enrichment of HDL a factor in its decrease. J. Lipid Res. 37, 2662-2674.
21. Calabresi, L., Franceschini, G., Sirtori, C. R., Plama, A. De., Saresella, M., Ferrante, P ., and Taramelli, D. (1997). Inhibition of VCAM-1 expression in endothelial cells by reconstituted high density lipoproteins. Biochem. Biophys. Res. Commun. 238, 61-65.
22. Cao, X., Koski, R. A., Gashler, A., McKiernan, M., Morris, C. F., Gaffney, R., Hay, R. V ., and Sukhatme, V. P. (1990). Identification and characterisation of the Egr-1 gene product, a DNA-binding zinc finger protein induced by differentiation and growth signals. Mol. Cell. Biol. 10, 1931-1939.
23. Chajek-Shaul, T., Hayek, T., Walsh, A ., and Breslow, J. L. (1991). Expression of the human apolipoprotein A-I gene in transgenic mice alters high density lipoprotein (HDL) particle size distribution and diminishes selective uptake of HDL cholesteryl esters. Proc. Natl. Acad. Sei. USA 88, 6731-6735.
24. Chen, J. K., Hoshi, H., McClure, D. B ., and McKeehan, W. L. (1986). Role of lipoproteins in growth of human adult arterial endothelial and smooth muscle cells in low lipoproteindeficient serum. J. Cell Physiol. 129, 207-214.
25. Chen, L. Y ., and Mehta, J. L. (1994). Inhibitory effect of high-density lipoprotein on platelet function is mediated by increase in nitric oxide synthase activity in platelets. Life Sei. 55, 1815-1821.
26. Cockerill, G. W., Rye, K.-A., Gamble, J. R., Vadas, M. A ., and Barter, P. (1995). High-density lipoproteins inhibit cytokine-induced expression of endothelial cell adhesion molecules. Arterioscler. Thromb. Vase. Biol. 15, 1987-1994.
27. Cockerill, G. W., Saklatraley, J., Ridley, S. H., Yarwood, H., Miller, N. E., Orae, B., Nithyanathan, S., Taylor, G., Haskard, D. O. (1998). High-density lipoproteins differentially modulate cytokine-induced expression of E-selectin and cyclooxygenase-2. Arterioscler. Thromb. Vase. Biol., in press.
28. Cogny, A., Paul, J. L., Atger, V., Soni, T ., and Moatti, N. (1994). Structural changes of highdensity lipoproteins following incubation with human polymorphonuclear cells. EUT. J. Biochem. 222, 965-973.
29. Cooke, J. P ., and Tsao, P. S. (1994). Is NO an endogenous antiatherogenic molecule? Arterioscler. Tliromb. 14, 653-655.
30. Cornwall, T. L., Arnold, E., Boerth, N. J ., and Lincoln, T. M. (1994). Incubation of smooth muscle cell growth by nitric oxide and activation of cAMP-dependent protein kinase by cGMP. Am. J. Physiol C 267,1404-1413.
31. Darbon, J.-M., Tournier, J.-R, Tauber, J.-P ., and Bayard, F. (1988). Possible role of protein phosphorylation in the mitogenic effect of high density lipoproteins on cultured vascular endothelial cells. J. Biol. Chem. 261, 8002-8008.
32. Davies, M. J. (1995). Acute coronary thrombosis-The role of plaque disruption and its initiation and prevention. Eur. Heart J. 16, 3-7.
33. Davies, M. J., Woolf, N., Rowles, P. M ., and Pepper, J. (1988). Morphology of the endothelium over atherosclerotic plaques in human coronary areteries. Br. Heart J. 60, 459-464.
34. Dawson, S ., and Henney, A. (1992). The status of PAI-1 as a risk factor for arterial and thrombotic disease: A review. Atherosclerosis 95, 105-117.
35. Dejana, E., Zanetti, A ., and Del Maschino, A. (1996). Adhesive proteins at endothelial cellto-cell junctions and leukocyte extravasation. Haemostasis 26, 210-219.
36. Des Mouliere, A., Badid, C, Cochalon-Piallat, M. L ., and Gabbiani, G. (1997). Apoptosis during wound healing, fibrocontractive disease and vascular wall injury. Int. J. Biochem. Cell Biol. 29, 19-30.
37. Drobnik, W., Mollers, C, Resink, T ., and Schmilz, G. (1995). Activation of phosphatidylinositol-speciflc phospholipase C in response to HDL3 and LDL is markedly reduced in cultured fibroblasts from Tangier patients. Arterioscler. Thromb. Vase. Biol. 15, 1369-1377.
38. Dubin, D., Pratt, R. E., Cooke, J. P ., and Dzau, V. J. (1989). Endothelin, a potent vasoconstrictor, is a vascular smooth muscle mitogen. J. Vase. Med. Biol 1, 50-154.
39. Dusserre, E., Pulcini, T., Bourdillon, M. C ., and Berthezene, F. (1993). High-density lipoprotein 3 stimulates phosphatidylcholine breakdown and sterol translocation in rat aortic smooth muscle cells by a phospholipase C/protein kinase C-dependent process. Biochem. Med. Metab. Biol 52, 45-52.
40. Epand, R. M., Stafford, A., Leon, B., Lock, P. E., Tytler, E. M., Segrest, J. P ., and Anantharamaiah, G. M. (1994). HDL and apolipoprotein A-I protect erythrocytes against the generation of procoagulant activity. Arterioscler. Thromb. 14,1775-1783.
41. Evensen, S. A. (1979). Injury to cultured endothelial cells: The role of lipoproteins and thromboactive agents. Haemostasis 8, 203-210.
42. Favre, G., Tazi, K. A., LeGaillard, F., Bennis, F., Hachem, H ., and Soula, G. (1993). High density lipoprotein.3 binding sites are related to DNA biosynthesis in adenocarcinoma cell line A549. J. Lipid Res. 34, 1093-1106.
43. Fischer-Dzoga, K ., and Wissler, R. W. (1976). Stimulation of proliferation in stationary primary cultures of monkey aortic smooth muscle cells. Part 2. Effect of varying concentrations of hyperlipemic serum and low density lipoproteins of varying dietary fat origins. Atherosclerosis 24, 515-525.
44. Fischer-Dzoga, K., Chen, R ., and Wissler, R. W. (1974). Effects of serum lipoproteins on the morphology, growth, and metabolism of arterial smooth muscle cells. Adv. Exp. Med. Biol 43, 299-311.
45. Fischer-Dzoga, K., Fraser, R ., and Wissler, R. W. (1976). Stimulation of proliferation in stationary primary cultures of monkey and rabbit aortic smooth muscle cells. I. Effects of lipoprotein fractions of hyperlipemic serum and lymph. Exp. Mol Palhol. 27, 346-359.
46. Fleischer, L. N., Tall, A. R., Witt, L. D., Muller, R. W ., and Cannon, P. J. (1982). Stimulation of arterial endothelial cell prostacyclin synthesis by high density lipoproteins. J. Biol Chem. 257, 6653-6655.
47. Fukuo, K., Nakahashi, T., Nomura, S., Hata, S., Suhara, T., Shimizu, M., Tamatani, M., Morimoto, S., Kitamura, Y ., and Ogihara, T. (1997). Possible participation of Fas-mediated apoptosis in the mechanism of atherosclerosis. Gerontology 43, 35-42.
48. Furchgott, R. F ., and Zawadzki, J. V. (1980). The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288, 373-376.
49. Galle, J., Ochslen, M., Schollmeyer, P ., and Wanner, C. (1994). Oxidised lipoproteins inhibit endothelium-dependent vasodilatation. Effects of pressure and high-density lipoprotein. Hypertension 23, 556-564.
50. Garver, W. S., Hokland, B., Champagne, J ., and Oram, J. F. (1994). Novel HDL binding proteins in bovine aortic endothelial cell membranes are isoforms of T-cadherin. Circulation 90, 240.
51. Geng, Y.-J ., and Libby, P. (1995). Evidence for apoptosis in advanced human atheroma. Am. J. Palhol. 147, 251-266.
52. Gerrity, R. G. (1981). The role of the monocyte in atherogenesis. Am. J. Pathol. 103,181-190.
53. Gerrity, R. G., Naito, H. K., Richardson, M ., and Schwartz, C. J. (1979). Dietary induced atherogenesis in swine: Morphology of the intima in prelesion stages. Am. J. Palhol. 95, 775-792.
54. Gordon, T., Castelli, \V. P., Hjortland, M. C, Kannel, W. B ., and Dawber, T. R. (1977). High density lipoprotein as a protective factor against coronary heart disease: The Framingham Study. Am. J. Med. 62, 707-714.
55. Gordon, T., Probstfield, J. L., Garrison, J. R., Neaton, J. D., Castelli, W. P., Knoke, J. D., Jacobs, D. R., Jr., Bangdiwala, S ., and Tyroler, H. A. (1989). High-density lipoprotein cholesterol and cardiovascular disease: Four prospective American studies. Circulation 79, 8-15.
56. Gross, S. S ., and Wolin, M. S. (1995). Nitric oxide: Pathophysiological mechanism. Annti. Rev. Physiol. 57, 737-769.
57. Hamilton, K. K ., and Sims, P. J. (1991). The terminal compliment protein C5b-9 augments binding of high density lipoprotein and its apolipoproteins AI and AH to human endothelial cells. J. Clin. Invest. 88, 1833-1840.
58. Hamilton, K. K., Zhao, J ., and Sims, P. J. (1993). Interaction between apolipoproteins A-I and A-II and the membrane attack complex of complement. J. Biol. Client. 268,3632-3638.
59. Han, D. K. M., Haudenschild, C. C, Hong, M. K., Tinlke, B. T., Leon, M. B ., and Liau, G. (1995). Evidence for apoptosis in human atherogenesis and in a rat vascular injury model. Am. J. Pathol 147, 267-277.
60. Haverkate, F., Thomspon, S. G., Pykem, S. D., Gallimore, J. R ., and Pepys, M. B. (1997). Production of C-reactive protein and risk of coronary events in stable and unstable angina. Lancet 349, 462-466.
61. Hekman, C. M ., and Loskutoff, D. J. (1987). Fibrinolytic pathways and the endothelium. Sem. Thromb. Hemost. 13, 514-527.
62. Hellsten, G., Boman, K., Bjerle, P., Blom, P ., and Nilsson, T. K. (1992). Increased plasminogen activator inhibitor and tissue plasminogen activator levels in subjects with electrocardiographic abnormality indicative of ischaemic heart disease: A cross-sectional study in Norsjo, Sweden. Eur. Heart J. 13, 57-60.
63. Hessler, J. R., Robertson, A. L ., and Chisolm, G. M. (1979). LDL-induced cytotoxicity and its inhibition by HDL in human vascular smooth muscle and endothelial cells in culture. Atherosclerosis 32, 213-329.
64. Hidaka, H ., and Fidge, N. H. (1992). Affinity purification of the hepatic high density lipoprotein receptor identifies two acidic glycoproteins and enables characterisation of their binding properties. Biochem. J. 284, 161-167.
65. Huffman, J. S ., and Benditt, E. P. (1982). Changes in high density lipoprotein content following endotoxin administration in the mouse. Formation of serum amyloid protein-rich subfractions. J. Biol. Chem. 257,10510-10517.
66. Hokland, B., Mendez, A. J ., and Oram, J. F. (1992). Cellular characterization of proteins that bind high density lipoprotein. J. Lipid Res. 33, 1335-1342.
67. Hokland, B. M., Scotte, J. P., Bierman, E. L ., and Qram, J. F. (1993). Cyclic AMP stimulates efflux of intracellular sterol from cholesterol-loaded cells. J. Biol. Chem. 268,25343-25349.
68. Horio, T., Kohno, M., Yasanuri, K., Murakawa, K., Yokokawa, K., Ikeda, M, Fukui, T ., and Tekada, T. (1993). Stimulation of endothelin-1 release by low density and very low density lipoproteins in cultured human endothelial cells. Atherosclerosis 101,185-190.
69. Hu, R.-M., Chuang, M.-Y., Prins, B., Kashyap, M. L., Frank, H. J. L., Pedram, A ., and Levin, E. R. (1994). High density lipoproteins stimulate the production and secretion of endothelin1 from cultured bovine aortic endothelial cells. J. Clin. Invest. 93, 1056-1062.
70. Jambou, D., Dejour, N., Bayer, P., Poiree, J.-C., Fredenrich, A., Issa-Sayegh, M., AdjoviDesouza, M., Lapalus, P ., and Harter, M. (1993). Effect of human native low-density and high-density lipoproteins on prostaglandin production by mouse macrophage cell line P388D1: Possible implications of pathogenesis of atherosclerosis. Biochim. Biophys. Acta 1168,115-121.
71. Jougasaki, M., Kiyotaka, M., Saito, Y., Nakao, H., Imura, H ., and Yasue, H. (1992). Suppression of endothelin-1 secretion by lysophosphatiylcholine in oxidized low density lipoprotein in cultured vascular endothelial cells. Circ. Res. 71, 614-619.
72. Kaneko, T., Wada, H., Wakita, Y., Minamikawa, K., Nakase, T., Mori, Y., Deguchi, K ., and Shirakawa, S. (1994). Enhanced tissue factor activity and plasminogen activator inhibitor1 antigen in human umbilical vein endothelial cells incubated with lipoproteins. Blood Coag. Fibrinol. 5, 385-392.
73. Kato, H. (1996). Tissue factor pathway inhibitor: Its structure function and clinical significance. Pol. J. Pharmacol. 48, 67-72.
74. Kaur, P., Welch, W. J ., and Saklatvala, J. (1989). Interleukin 1 and tumour necrosis factor increase phosphorylation of the small heat shock protein. Effects in fibroblasts, Hep G2 and U937 cells. FEBS Lett. 258, 269-273.
75. Khedera, A., Kawai, Y., Kayashita, J ., and Kato, N. (1996). Feeding rats the nitric oxide synthase inhibitor L-N(omega) nitrosarginine, elevates serum triglycerides and cholesterol and lowers hepatic fatty acid oxidation. J. Nulr. 126, 2563-2567.
76. Kitamura, A., Iso, H., Naito, Y., lida, M., Konishi, M., Folsom, A., Sato, S., Kiyama, M., Nakamura, M., Sankai, T., Shimamoto, T ., and Komachi, Y. (1994). High-density lipoprotein cholesterol and premature coronary heart disease in urban Japanese men. Circulation 89, 2533-2539.
77. Koller, E., Koller, F ., and Binder, B. R. (1989). Purification and identification of the lipoproteinbinding proteins from human blood platelet membrane. J. Biol. Chem. 264, 12412-12418.
78. Kovanen, P. T. (1993). The mast cell-A potential link between inflammation and cellular cholesterol deposition in atherogenesis. Etir. Heart J. 14, (Suppl. K), 105-107.
79. Kume, N ., and Gimbrone, M. A., Jr., (1994). Lysophosphatidylcholine transcriptionally induces growth factor gene expression in cultured human endothelial cells. J. Clin. Invest. 93, 907-911.
80. Kume, N., Cybulsky, M. I ., and Gimbrone, M. A., Jr. (1992). Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells. J. Clin. Invest. 90, 1138-1144.
81. Kumon, Y., Suehiro, T., Ikeda, Y., Yoshida, K., Hashimoto, K ., and Ohno, F. (1993). Influence of serum amyloid A protein on high-density lipoprotein in chronic inflammatory disease. Clin. Biocliem. 26, 505-511.
82. Kushner, I. (1982). The phenomenon of the acute phase response. Ann. N.Y. Acad. Sei. 389, 39-48.
83. Landschulz, K. T., Pathak, R. K., Rigotti, A., Krieger, M ., and Hobbs, H. (1996). Regulation of scavenger receptor, class B, type I, a high density lipoprotein receptor, in liver and steroidogenic tissues of the rat. J. Clin. Invest. 98, 984-995.
84. Levin, E. G., Miles, L. A., Fless, G. M., Scann, A. M., Baynhaus, P., Curtiss, L. K ., and Plow, E. F. (1994). Lipoprotein inhibits the secretion of tissue plasminogen activator from human endothelial cells. Arterioscler. Tliromb. 14, 438-442.
85. Libby, P., Wyler, D. J., Janicka, M. W., and Dinarello, C. A. (1985). Differential effects of human interleukin-1 on growth of human fibroblasts and vascular smooth muscle cells. Arteriosclerosis 5, 186-191.
86. Libby, P., Genz, Y. J., Aikawa, M., Schoenenbeck, U., Mach, F., Clinton, S. K., Sukova, G. K., and Lee, R. T. (1996). Macrophage and atherosclerotic plaque stability. Curr. Opin. Lipidol. 7, 330-335.
87. Lincoln, T. M., Komalavilas, P., and Cornwell, T. L. (1994). Pleiotropic regulation of vascular smooth muscle tone by cyclic GMP-dependent protein kinase. Hypertension 23,1141-1147.
88. Linstedt, L., Lee, M., Castro, G. R., Fruchart, J. C, and Kovanen, P. T. (1996). Chymase in exocytosed rat mast cell granules effectively proteolyzes apolipoprotein AI-containing lipoproteins, so reducing the cholesterol efflux-inducing ability of serum and oartic intimal fluid. J. Clin. Invest. 97, 2174-2182.
89. Loscalzo, J. (1989). Thrombolysis in the management of acute myocardial infarction and unstable angina pectoris. Drugs 37, 191-204.
90. Luscinskas, F. W., Brock, A. F., Aranout, M. A., and Gimbrone, M. A., Jr. (1989). Endothelialleukocyte adhesion molecule-1-dependent and leukocyte (CDll/CD18)-dependent mechanisms contribute to polymorphonuclear leukocyte adhesion to cytokine-activated human vascular endothelial cells. J. Immiinol. 142, 2257-2263.
91. Mackness, M. I., Abbot, C., Arrol, S., and Durrington, P. N. (1993). The role of high-density lipoprotein and lipid-soluble antiosidant vitamins in inhibiting low-density lipoprotein oxidation. Biochem. J. 294, 829-834.
92. Maes, M., Smith, R., Christophe, A., Vandoolaeghe, E., Van Gastel, A., Neels, H., Demedts, P., Wauters, A., and Meltzer, H. Y. (1997). Lower serum high-density lipoprotein cholesterol (HDL-C) in major depression and in depressed men with serious suicidal attempts: Relationship with immune-inflammatory markers. Acta Psych. Scand. 95, 212-221.
93. Matsuda, Y., Hirata, K., Onoue, N., Suematsu, M., Kawashima, S., Akita, H., and Yokoyama, M. (1993). High density lipoprotein reverses inhibitory effect of oxidised low density lipoprotein on endothelium-dependent arterial relaxation. Circ. Res. 72, 1103-1109.
94. Maier, J. A. M., Barenghi, L, Pagani, F., Badamante, S., Corri, P., and Ragnotti, G. (1994). The protective role of high-density lipoprotein on oxidized-low-density-lipoprotein-induced U937/endothelial cell interactions. Eur. J. Biochem. 221, 35-41.
95. McKnight, G. L., Reasoner, J., Gilbert, T., Sundquist, K. O., Hokland, B., McKernan, P. A., Champagne, J., Johnson, C. J., Bailey, M. C., Holly, R., O'Hara, P. J., and Oram, J. F. (1992). Cloning and expression of a cellular high density lipoprotein-binding protein that is up-regulated by cholesterol loading of cells. J. Biol. Chem. 267, 12131-12141.
96. Meek, R. L., Urieli-Shoval, S., and Benditt, E. P. (1994). Expression of apolipoprotein serum amyloid A mRNA in human atherosclerotic lesions and cultured vascular cells: Implications for serum amyloid A function. Proc. Natl. Acad. Sei. USA 91, 3186-3190.
97. Mehta, J. L., and Chen, L. Y. (1995). Reversal by high-density lipoprotein of the effect of oxidised low-density lipoprotein on nitric oxide synthase protein expression in human platelets. J. Lab. Clin. Med. 127, 287-295.
98. Miller, G. J., and Miller, N. E. (1979). Plasma-high-density-lipoprotein concentration and development of ischemic heart-disease. Lancet 1, 16-19.
99. Mollers, C., Drobnik, W., Resink, T., and Schmilz, G. (1995). HOL and LDL mediated signal transduction in cultured human fibroblasts. Cell. Signalling 7, 695-707.
100. Murugesan, G., Sa, G., and Fox, P. L. (1994). High-density lipoprotein stimulates endothelial cell movement by a mechanism distinct from basic fibroblast growth factor. Circ. Res. 74, 1149-1156.
101. Murohara, T., Delyani, J. A., Albelda, S. M., and Lefer, A. M. (1996). Blockade of PECAM-1 protects against myocardial ischemia and reperfusion injury in cats. J. Immiinol. 156,3550-3557.
102. Myers, D. E., Huang, W. N., and Larkins, R. G. (1996). Lipoprotein-induced prostacyclin production in endothelial cells and effects of lipoprotein modification. Am. J. Pliysiol. 271, C1504-C1511.
103. Navab, M., Imes, S. S., Hama, S. Y., Hughes, G. P., Ross, L. A., Bork, R. N., Velente, J. A., Berliner, J. A., Drinkwater, D. G, and Fogelman, A. M. (1991). Monocyte transmigration induced by modification of low density lipoprotein in cocultures of human aortic wall cells is due to induction of monocyte chemotactic protein I synthesis and is abolished by high density lipoprotein. J. Clin. Invest. 88, 2039-2046.
104. 3 stimulated platelets. Thromb. Res. 59, 913-920.
105. Nazih, H., Devred, D., Martin-Nizard, F., Clavey, V., Fruchart, J. G, and Delbart, C. (1992). Pertussis toxin sensitive G-protein coupling of HDL receptor to phospholipase C in human platelets. Thromb. Res. 67, 559-567.
106. Nazih, H., Nazih-Sanderson, F., Magret, V., Caron, B., Goudemand, J., Fruchart, J. G, and Delbart, G (1994). Protein kinase C-dependent desensitization of HDL3-activated phospholipase C in human platelets. Arterioscler. Thromb. 14, 1321-1326.
107. Negre-Salvaryre, A., Fitoussi, G., Reand, V., Pieraggi, M. C., Thiers, J. C., and Salvaryre, R. (1992). A delayed and sustained rise of cytosolic calcium is elevated by oxidised low density lipoprotein in cultured bovine aortic endothelial cells. FEBS Letts. 299, 60-65.
108. Neverov, N. I., Kaysen, G. A., Nuccitelli, R., and Weiss, R. H. (1997). HDL causes mesangial cell mitogenesis through a tyrosine kinase-dependent receptor mechanism. J. Am. Soc. Nephrol. 8, 1247-1256.
109. Nofer, J.-R., Walter, M., Kehrel, B., Seedorf, U., and Assman, G. (1995). HDL3 activates phospholipase D in normal but not in glycoprotein Ilb/IIIa-deficient platelets. Biochem. Biophys. Res. Commun. 207, 148-154.
110. + antiport in human platelets. Thromb. llaem. 75, 635-641.
111. Ong, A. G M., Jowett, T. P., Moorhead, J. F., and Owen, J. S. (1994). Human high density lipoproteins stimulate endothelin-1 release by cultured human proximal tubular cells. Kidney Int. 46, 1315-1321.
112. Orlov, S., Resink, T. J., Bernhardt, J., Ferracin, F., and Buhler, F. R. (1993). Vascular smooth muscle cell calcium fluxes. Hypertension 21,195-203.
113. Oseroff, A., Krishnamurti, G, Hassett, A., Tang, D., and Alving, B. (1989). Plasminogen activator and plasminogen activator inhibitor activities in men with coronary artery disease. J. Lab. Clin. Med. 113, 88-93.
114. Packman, C. H., Rosenfeld, S., and Leddy, J. P. (1985). High-density lipoprotein and its apolipoproteins inhibit cytolytic activity of complement. Studies on the nature of inhibitory moiety. Biochim. Biophys. Acta 812, 107-111.
115. Parhami, F., Fang, Z., Fogelman, A., Andalibi, A., Territo, M., and Berliner, J. (1993). Minimally modified low density lipoprotein-induced inflammatory responses in endothelial cells are mediated by cyclin adenosine monophosphate. J. Clin. Invest. 92, 471-478.
116. Park, G T., Creasey, A. A., and Wright, S. D. (1997). Tissue factor pathway inhibitor blocks cellular effects of endotoxin by binding to endotoxin and interfering with transfer to CD14. Blood 89, 4268-4274.
117. Paszty, G, Maeda, N., Verstuyft, J., and Rubin, E. M. (1994). Apolipoprotein AI transgene corrects apolipoprotein E deficiency-induced atherosclerosis in mice. J. Clin. Invest. 94, 899-903.
118. Peto, J., Mihai, K., and Makary, A. (1991). Low level of prostacyclin as a risk of ischaemic heart disease. Int. J. Cardiol. 30, 237-239.
119. Pomerantz, K. B., Fleisher, L. N., Tall, A. R., and Cannon, P. J. (1984). High density lipoproteins provide arachidonate for endothelial cell prostacyclin synthesis. Trans. Assoc. Am. Physicians 97, 275-282.
120. Radomski, M. W., Palmer, R. M. J., and Moncada, S. (1987a). The anti-aggregating properties of vascular endothelium: Interactions between prostacyclin and nitric oxide. Br. J. Pliarmacol 92, 639-646.
121. Radomski, M. W., Palmer, R. M., and Moncada, S. (1987b). Endogenous nitric oxide inhibits platelet adhesion to vascular endothelium. Lancet 2,1057-1058.
122. Rajagopalan, S., Meng, X. P., Ramasamy, S., Harrison, D. G., and Galis, Z. S. (1996). Reactive oxygen species produced by macrophage-derived foam cells regulate the ability of vascular cell metalloproteinases in vitro. Implication for atherosclerotic plaque stability. J. Clin. Invest. 98, 2572-2579.
123. Regazzi, R., Eppenberger, U., and Fabbro, D. (1988). The 27,000 daltons stress proteins are phosphorylated by protein kinase C during the tumor promoter-mediated growth inhibition of human mammary carcinoma cells. Blochim. Biopliys. Acta 153, 62-68.
124. Resink, T. J., Bochov, V. N., Hahn, A. W. A., Philippova, M. P., Buhler, F. R., and Tkachuk, V. A. (1993a). Low- and high-density lipoproteins as mitogenic factors for vascular smooth muscle cells: Individual, additive and synergistic effects. J. Vase. Res. 32, 328-338.
125. Resink, T. J., Rybin, V., Bernhardt, J., Orlov, S., Buhler, F., and Tkachuk, V. (1993b). Cellular signalling by lipoproteins in cultured SMC from spontaneously hypertensive rats. J. Vase. Res. 10, 169-180.
126. Resnick, N., and Gimbrone, M. A., Jr. (1995). Hemodynamic forces are complex regulators of endothelial gene expression. FASEB J. 9, 874-882.
127. Richardson, B. C., Lalwani, N. D., Johnson, K. J., and Marks, R. (1994). Fas ligation triggers apoptosis in macrophages but not endothelial cells. Ear. J. Immunol. 24, 2640-2645.
128. Riedy, M. A., and Schwartz, S. M. (1981). Endothelial regeneration (III). Time course of initial changes after small defined injury to rat aortic endothelium. Lab. Invest. 44,301-308.
129. Riedy, M. A., Clowes, A. W., and Schwartz, S. M. (1983). Endothelial regeneration. V. Inhibition of endothelial regrowth in arteries of rat and rabbit. Lab. Invest. 49, 569-575.
130. Rossenfeld, S. I., Packman, C. H., and Leddy, J. P. (1983). Inhibition of lytic action of cell-bound terminal complement-components by human high density lipoproteins and apoproteins. J. Clin. Invest. 71, 795-802.
131. Ross, R. (1993). The pathogenesis of atherosclerosis: A perspective for the 1990s. Nature 362, 801-809.
132. Ross, R., and Glomset, J. A. (1973). Atherosclerosis and the arterial smooth muscle cell: Proliferation of smooth muscle is a key event in the genesis of the lesions of atherosclerosis. Science 180, 1332-1339.
133. Rubin, E. M., Krauss, R. M., Spangler, E. A., Verstuyft, J. G., and Clift, S. M. (1991). Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AI. Nature 353,265-267.
134. Ryan, J., Benedict, C., and Stern, D. (1994). Endothelial cell progoagulants. Life Sei. 6,18-22.
135. Sachinidis, A., Ko, Y., Wieczorek, A., Weisser, B., Locher, R., Vetter, W., and Vetter, H. (1993). Lipoproteins induce expression of the early growth response gene-1 in vascular smooth muscle cells from rat. Biochem. Biophys. Res. Commun. 192, 794-799.
136. Schaefer, H. I. M. P., Hold, C. M., Egas-Kenniphaas, J. M., and Van der Laase (1993). Intracellular calcium signaling after binding of low-density lipoprotein to confluent and non-confluent cultures of endothelial cell line EA.hy926. Cell Calcium 14, 507-516.
137. Schmilz, G., Robenek, H., Lohmann, U., and Assman, G. (1985a). Interaction of high density lipoprotein with cholesteryl ester-laden macrophages: Biochemical and morphological characterization of cell surface receptor binding, endocytosis and resecretion of high density lipoprotein by macrophages. EMBO J. 4, 613-622.
138. Schmilz, G., Neimann, R., Brennhausen, B., Krause, R., and Assman, G. (1985b). Regulation of HDL receptors in cullured macrophages: Role of ACAT. EMBO J. 4, 2773-2779.
139. Soma, M., Donelti, E., Parolini, C., Sirtori, C. R., Fumagelli, R., and Franceschinni, G. (1994). Recombinanl apolipoprolein A-Imilano dimer inhibils carolid inlimal Ihickening induced by perivascular manipulalion in rabbils. Circ. Res. 76, 405-411.
140. Soutar, A. K., and Myant, N. B. (1972). Plasma lipoproteins. Int. Rev. Biochem. 25, 55-119.
141. Speidel, M. T., Booyse, F. M, Abrams, A., Moore, M. A., and Chung, B. H. (1990). Lipolyzed hypertriglyceridemic serum and triglyceride-rich lipoprotein caused lipid accumulation in and are cytotoxic to cultured human endothelial cells. High density lipoproteins inhibit this cytotoxicity. Thromb. Res. 58, 251-264.
142. Springer, T. A. (1990). Adhesion receptors of the immune system. Nature 346, 425-434.
143. Stemme, S., and Hansson, G. K. (1994). Immune mechanisms in atherogenesis. Ann. Med. 26,141-146.
144. Su, Z., Luo, Z. H., Niu, X. L., and Guo, Z. G. (1996). High density lipoproteins increase cytoplasmic free calcium in bovine aortic endothelial cells. J. Lipid Med. Cell. Signal. 15, 5-15.
145. Sue, I., Escargueil-Blanc, I., Troly, M., Salvayre, R., and Negre-Salvayre, A. (1997). HDL and ApoA prevent cell death of endothelial cells induced by oxidised LDL. Arterioscler. Thromb. Vase. Biol. 17, 2158-2166.
146. Sukhatme, V. P. (1990). Early transcriptional events in cell growth: The Egr family. J. Am. Soc. Nephrol. 1, 859-866.
147. Sukhatme, V. P., Cao, X., Chang, L. C, Tsai-Morris, C. H., Stamenkovich, D., Ferreira, P. C. P., Cohen, D. R., Edwards, S. A., Shows, T. B., Curran, T., LeBeau, M. M., and Adamson, E. D. (1988). A zinc finger-encoding gene coregulated with c-fos during growth and differentiation, and after cellular depolarization. Cell 53, 37-43.
148. 2+-induced phospholipid redistribution in the human erythrocyte membrane. J. Biol. Chem. 269, 6347-6354.
149. Tamagaki, T., Sawada, S., Imamura, H., Tada, Y., Yamasaki, S., Toratani, A., Sato, T., Komatsu, S., Akamatsu, N., Yamagami, M., Kobayashi, K., Kato, K., Yamamoto, K., Shirai, K., Yamada, K., Higaki, T., Nakagawa, K., Tsuji, H., and Nakagawa, M. (1995). Effects of high-density lipoproteins on intracellular pH and proliferation of human vascular endothelial cells. Atherosclerosis 123, 73-82.
150. Tauber, J.-P., Cheng, J., and Gospodarowicz, D. (1980). Effect of high and low density lipoproteins on proliferation of cultures bovine vascular endothelial cells. J. Clin. Invest. 66, 696-708.
151. Tauber, J.-P., Cheng, J., Massoglia, S., and Gospodarowicz, D. (1981). High density lipoproteins and the growth of vascular endothelial cells in serum-free medium. In Vitro 17, 519-530.
152. Tazi, C. A., Bonnafous, M., Favre, G., Soula, G., and Le Gaillard, F. (1995). Involvement of the Ca2t-dependent phosphorylation of a 20kDa protein in the proliferative effect of high-density lipoproteins (subclass 3) on the adenocarcinoma cell line A549. Biochem. J. 307, 557-561.
153. Uint, L., and Mendez, A. J. (1994). Protein kinase C down-regulation inhibits cholesterol efflux mediated by apoprotein A-I but not by HDL in cultured cells. Circulation 90,240. [Abstract]
154. Ureili-Shoval, A., Meek, R. L., Hanson, R. H., Eriksen, N., and Benditt, E. P. (1994). Human serum amyloid A genes are expressed in monocyte/macrophage cell line. Am. J. Patliol. 145, 650-660.
155. Vakeva, A., jauhiainen, M., Ehnholm, C., Lehto, T., and Meri, S. (1994). High-density lipoproteins can act as carriers of glycophosphoinositol lipid-anchored CD59 in human plasma. Immunology 82, 28-33.
156. Vallance, P., Collier, J., and Bhagat, K. (1997). Infection, inflammation, and infarction: Does acute endothelial dysfunction provide a link? Lancet 349, 1391-1392.
157. Van der Bom, J. G., de Knijff, P., Haverkate, F., Bots, M., Meijer, P., de Jong, P. T. V. M., Hofman, A., Kluft, C., and Grobbee, D. (1996). Tissue plasminogen activator and risk of myocardial infarction. The Rotterdam Study. Circulation 95, 2623-2627.
158. Vane, J. R., and Bolting, R. M. (1995). Pharmacodynamic profile of prostacyclin. Am. J. Cardiol. 75, 3A-10A.
159. Van Lenten, B. J., Kama, S. Y., de Beer, F. C, Stafforini, D. M., Mclntyre, T. M., Prescott, S. M., LaDu, B. N., Fogelman, A. M., and Navab, M. (1995). Antiinflammatory HDL becomes pro-inflammatory during acute phase response. Loss of protective effect of HDL against LDL oxidation in aortic wall cell co-culture. J. Clin. Invest. 96, 2758-2767.
160. Velican, C., and Velican, D. (1980). The precursors of coronary atherosclerotic plaques in subjects up to the age of 40 years old. Atherosclerosis 37, 33-46.
161. Vries, H. E., Breedveld, B., Kuiper, J., De Boer, A. G., Van Berkel, T. J. C, and Breimer, D. D. (1995). High-density lipoprotein and cerebral endothelial cells in vitro: Interactions and transport. Biochem. Pharnyicol. 50, 271-273.
162. Wada, W. H., Moni, Y., Kaneko, T., Wakita, Y., Nakase, T., Minimikawa, K., Ohura, M., Tamaki, S., Tamgawa, M., kageyanas, S., et al. (1993). Elevated plasma levels of vascular endothelial cell markers on patients with hypercholesterolemia. Am. J. Hematol. 44,112-116.
163. Walter, M., Reinecke, H., Nofer, J.-P., Seedorf, U., and Assman, G. (1995). HDL3 stimulates multiple signaling pathways in human skin fibroblasts. Arterioscler. Thromb. Vase. Biol. 15, 1975-1986.
164. Walter, M. T., Stevenson, F. K., Goswami, R., Smith, J. L., and Cowley, M. I. (1989). Comparison of serum and synovial fluid concentration of beta-2-microglobulin and C reactive proteins in relation to clinical disease active macrophage synovial inflammation in rheumatoid arthritis. Ann. Rheum. Dis. 48, 905-911.
165. Wang, J., Wang, S., Lu, Y., Weng, Y., and Gown, A. M. (1994). GM-CSF and M-CSF expression is associated with macrophage proliferation in progressing and regressing rabbit atheromatous lesions. Exp. Mol Pathol. 61,109-118.
166. Wang, N., Weng, W., Breslow, J. L., and Tall, A. R. (1996). Scavenger receptor Bl (SR-B1) is upregulated in adrenal gland in apolipoprotein A-I and hepatic lipase knock-out mice as a response to depletion of cholesterol stores. In vivo evidence that SR-B1 is a functional HDL receptor under feedback control. J. Biol. Chem. 271, 21001-21004.
167. Wissler, R. W. (1984). Principles of the pathogenesis of atherosclerosis. In "Heart Disease" (E. Braunwald, ed). Saunders, Philadelphia.
168. Woodhouse, P. R., Meade, T. W., and Khaw, K.-Y. (1994). Plasminogen activator inhibitor1, the acute phase response and vitamin C. Atherosclerosis 133, 71-76.
169. Wu, Y. Q., and Handweger, S. (1992). HDL stimulates molecular weight SOkDa protein phosphorylation in human trophoblast cells. Evidence for a protein kinase C dependent pathway in human placental lactogen release. Endocrinology 131, 2935-2940.
170. Wu, Y. Q., Jorgensen, V., and Handweger, S. (1988). HDL stimulates placental lactogen release and adenosine 3'5' monophosphate (cAMP) production in human trophoblast cells. Evidence for cAMP as a second messenger in human placental lactogen release. Endocrinology 131,1879-1884.
171. Yamigisawa, M., and Masaki, T. (1989). Molecular biology and biochemistry of the endothelins. Trends Pliarmacol. Sei. 10, 374-378.
172. Yamagisawa, M., Kurihara, H., Kimura, S., Tomobe, Y., Kobayashi, Y., Mitsui, Y., Yazaki, K., Goto, K., and Masaki, T. (1988). A novel vasoconstrictor peptide produced by vascular endothelial cells. Nature 332, 411-415.
173. Yui, Y., Aoyama, T., Morishita, H., Takahashi, M., Takatsu, Y., and Kawai, C. (1988). Serum prostacyclin (PGy stabilizing factor is identical to apolipoprotein A-I (apo A-I): A novel function of apo A-I. J. Clin. Invest. 82, 803-807.
174. Zeiher, A. M., Schachinger, V., Hohnloser, S. H., Saurbier, B., and Just, H. (1994). Coronary atherosclerotic wall thickening and vascular reactivity in humans. Circulation 89,2525-2532.
175. Zembowicz, A., Tanf, J., and Wu, K. K. (1995). Transcriptional induction of endothelial nitric oxide synthase type III by lysophosphatidylcholine. J. Biol. Cliem. 270,17006-17010.
176. Zhao, B. (1996). Role of lipoproteins in platelet activation. Blood Coag. Fibrin. 7, 270-273.
177. Zhao, B., Dierichs, R., Lui, B., and Holling-Rauss, M. (1994). Functional morphological alterations of human blood platelets induced by oxidised low density lipoproteins. Thromb. Res. 74, 293-301.
178. Zhao, B.( Zhang, Y., Liu, B., Nawroth, P., and Dierichs, R. (1995). Endothelial cells injured by oxidised low density lipoprotein. Am. J. Hemalol. 49, 250-252.
179. Zwijsen, R. M. L., De Haan, L. H. J., Kuivenhoven, J. A., and Nusselder, I. C. J. (1991). Modulation of low-density lipoprotein-induced inhibition of intercellular communication by antioxidants and high-density lipoproteins. Food Chem. Toxicol. 29, 615-620.